AChE is an attractive target and considered a therapeutically relevant strategy for drug design and discovery for the treatment of peripheral diseases, such as Alzheimer’s disease [17,18]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.